CERIBELL INC (CBLL) Stock Fundamental Analysis

NASDAQ:CBLL • US15678C1027

17.54 USD
-0.62 (-3.41%)
At close: Mar 3, 2026
17.75 USD
+0.21 (+1.2%)
After Hours: 3/3/2026, 4:30:06 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

CBLL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of CBLL is average, but there are quite some concerns on its profitability. CBLL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CBLL had negative earnings in the past year.
  • In the past year CBLL has reported a negative cash flow from operations.
CBLL Yearly Net Income VS EBIT VS OCF VS FCFCBLL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • CBLL has a Return On Assets of -27.28%. This is comparable to the rest of the industry: CBLL outperforms 44.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -34.38%, CBLL is in line with its industry, outperforming 53.26% of the companies in the same industry.
Industry RankSector Rank
ROA -27.28%
ROE -34.38%
ROIC N/A
ROA(3y)-31.74%
ROA(5y)N/A
ROE(3y)-46.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLL Yearly ROA, ROE, ROICCBLL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 87.89%, CBLL belongs to the top of the industry, outperforming 96.74% of the companies in the same industry.
  • CBLL's Gross Margin has improved in the last couple of years.
  • CBLL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.96%
GM growth 5YN/A
CBLL Yearly Profit, Operating, Gross MarginsCBLL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CBLL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CBLL has more shares outstanding than it did 1 year ago.
  • CBLL has a worse debt/assets ratio than last year.
CBLL Yearly Shares OutstandingCBLL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
CBLL Yearly Total Debt VS Total AssetsCBLL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • CBLL has an Altman-Z score of 9.06. This indicates that CBLL is financially healthy and has little risk of bankruptcy at the moment.
  • CBLL has a Altman-Z score of 9.06. This is amongst the best in the industry. CBLL outperforms 88.04% of its industry peers.
  • CBLL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • CBLL has a Debt to Equity ratio of 0.13. This is in the better half of the industry: CBLL outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 9.06
ROIC/WACCN/A
WACC10.09%
CBLL Yearly LT Debt VS Equity VS FCFCBLL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 9.73 indicates that CBLL has no problem at all paying its short term obligations.
  • The Current ratio of CBLL (9.73) is better than 91.30% of its industry peers.
  • CBLL has a Quick Ratio of 9.35. This indicates that CBLL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 9.35, CBLL belongs to the top of the industry, outperforming 91.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.73
Quick Ratio 9.35
CBLL Yearly Current Assets VS Current LiabilitesCBLL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The earnings per share for CBLL have decreased strongly by -29.54% in the last year.
  • CBLL shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.09%.
  • CBLL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.90% yearly.
EPS 1Y (TTM)-29.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)36.09%
Revenue growth 3Y50.9%
Revenue growth 5YN/A
Sales Q2Q%33.72%

3.2 Future

  • CBLL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.02% yearly.
  • The Revenue is expected to grow by 28.22% on average over the next years. This is a very strong growth
EPS Next Y-1.3%
EPS Next 2Y14.08%
EPS Next 3Y12.02%
EPS Next 5YN/A
Revenue Next Year28.3%
Revenue Next 2Y28.37%
Revenue Next 3Y28.22%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBLL Yearly Revenue VS EstimatesCBLL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
CBLL Yearly EPS VS EstimatesCBLL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • CBLL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CBLL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLL Price Earnings VS Forward Price EarningsCBLL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLL Per share dataCBLL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • CBLL's earnings are expected to grow with 12.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.08%
EPS Next 3Y12.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CBLL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CERIBELL INC

NASDAQ:CBLL (3/3/2026, 4:30:06 PM)

After market: 17.75 +0.21 (+1.2%)

17.54

-0.62 (-3.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners71.04%
Inst Owner Change5.97%
Ins Owners10.53%
Ins Owner Change-1.5%
Market Cap660.21M
Revenue(TTM)89.06M
Net Income(TTM)-53.41M
Analysts88.57
Price Target28.71 (63.68%)
Short Float %5.75%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.34%
Min EPS beat(2)12.27%
Max EPS beat(2)14.41%
EPS beat(4)4
Avg EPS beat(4)12.11%
Min EPS beat(4)5.13%
Max EPS beat(4)16.63%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.58%
Min Revenue beat(2)1.49%
Max Revenue beat(2)1.68%
Revenue beat(4)4
Avg Revenue beat(4)2.29%
Min Revenue beat(4)1.49%
Max Revenue beat(4)4.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.51%
PT rev (3m)13.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.41
P/FCF N/A
P/OCF N/A
P/B 4.25
P/tB 4.25
EV/EBITDA N/A
EPS(TTM)-1.47
EYN/A
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS2.37
BVpS4.13
TBVpS4.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.28%
ROE -34.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.89%
FCFM N/A
ROA(3y)-31.74%
ROA(5y)N/A
ROE(3y)-46.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.96%
GM growth 5YN/A
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 113.5%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.73
Quick Ratio 9.35
Altman-Z 9.06
F-Score3
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)153.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y-1.3%
EPS Next 2Y14.08%
EPS Next 3Y12.02%
EPS Next 5YN/A
Revenue 1Y (TTM)36.09%
Revenue growth 3Y50.9%
Revenue growth 5YN/A
Sales Q2Q%33.72%
Revenue Next Year28.3%
Revenue Next 2Y28.37%
Revenue Next 3Y28.22%
Revenue Next 5YN/A
EBIT growth 1Y-47.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.45%
OCF growth 3YN/A
OCF growth 5YN/A

CERIBELL INC / CBLL FAQ

Can you provide the ChartMill fundamental rating for CERIBELL INC?

ChartMill assigns a fundamental rating of 4 / 10 to CBLL.


What is the valuation status of CERIBELL INC (CBLL) stock?

ChartMill assigns a valuation rating of 0 / 10 to CERIBELL INC (CBLL). This can be considered as Overvalued.


Can you provide the profitability details for CERIBELL INC?

CERIBELL INC (CBLL) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CERIBELL INC?

The Earnings per Share (EPS) of CERIBELL INC (CBLL) is expected to decline by -1.3% in the next year.